These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 20976952

  • 1. [The incidence of extended spectrum beta-lactamases in Proteus mirabilis strains isolated in 2007-2009].
    Kwiecińska-Piróg J, Bogiel T, Gospodarek E.
    Przegl Epidemiol; 2010; 64(3):395-8. PubMed ID: 20976952
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Drug resistance and proticinogenic types of Proteus mirabilis isolated from urinary tract infections].
    Szymaniak L, Aleksandrowicz I, Giedrys-Kalemba S.
    Med Dosw Mikrobiol; 1999; 51(3-4):323-30. PubMed ID: 10803261
    [Abstract] [Full Text] [Related]

  • 6. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients.
    Saito R, Okugawa S, Kumita W, Sato K, Chida T, Okamura N, Moriya K, Koike K.
    Clin Microbiol Infect; 2007 Dec; 13(12):1204-6. PubMed ID: 17850340
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. VEB-6 extended-spectrum beta-lactamase-producing Proteus mirabilis from Sultanate of Oman.
    Potron A, Poirel L, Elhag K, Al Yaqoubi F, Nordmann P.
    Int J Antimicrob Agents; 2009 Nov; 34(5):493-4. PubMed ID: 19525094
    [No Abstract] [Full Text] [Related]

  • 14. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
    Luzzaro F, Brigante G, D'Andrea MM, Pini B, Giani T, Mantengoli E, Rossolini GM, Toniolo A.
    Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Outbreak caused by Proteus mirabilis isolates producing weakly expressed TEM-derived extended-spectrum β-lactamase in spinal cord injury patients with recurrent bacteriuria.
    Cremet L, Bemer P, Rome J, Juvin ME, Navas D, Bourigault C, Guillouzouic A, Caroff N, Lepelletier D, Asseray N, Perrouin-Verbe B, Corvec S.
    Scand J Infect Dis; 2011 Dec; 43(11-12):957-61. PubMed ID: 21888562
    [Abstract] [Full Text] [Related]

  • 17. [Prevalence of multidrug-resistant Proteus spp. strains in clinical specimens and their susceptibility to antibiotics].
    Reśliński A, Gospodarek E, Mikucka A.
    Med Dosw Mikrobiol; 2005 Dec; 57(2):175-84. PubMed ID: 16134389
    [Abstract] [Full Text] [Related]

  • 18. The impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea.
    Ahn JY, Ann HW, Jeon Y, Ahn MY, Oh DH, Kim YC, Kim EJ, Song JE, Jung IY, Kim MH, Jeong W, Ku NS, Jeong SJ, Choi JY, Yong D, Song YG, Kim JM.
    BMC Infect Dis; 2017 May 03; 17(1):327. PubMed ID: 28468622
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Extended-spectrum β-lactamase-producing Proteus mirabilis with multidrug resistance isolated from raw chicken in Singapore: Genotypic and phenotypic analysis.
    Guo S, Aung KT, Tay MYF, Seow KLG, Ng LC, Schlundt J.
    J Glob Antimicrob Resist; 2019 Dec 03; 19():252-254. PubMed ID: 31639544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.